Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.
2.

Boswellic acids in chronic inflammatory diseases.

Ammon HP.

Planta Med. 2006 Oct;72(12):1100-16. Review.

PMID:
17024588
3.

Modulation of the immune system by Boswellia serrata extracts and boswellic acids.

Ammon HP.

Phytomedicine. 2010 Sep;17(11):862-7. doi: 10.1016/j.phymed.2010.03.003. Epub 2010 Aug 8. Review. Erratum in: Phytomedicine. 2011 Feb 15;18(4):334.

PMID:
20696559
4.

Frankincense--therapeutic properties.

Al-Yasiry AR, Kiczorowska B.

Postepy Hig Med Dosw (Online). 2016 Jan 4;70:380-91. Review.

5.

Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data.

Abdel-Tawab M, Werz O, Schubert-Zsilavecz M.

Clin Pharmacokinet. 2011 Jun;50(6):349-69. doi: 10.2165/11586800-000000000-00000. Review.

PMID:
21553931
6.

Boswellic Acids and Their Role in Chronic Inflammatory Diseases.

Ammon HP.

Adv Exp Med Biol. 2016;928:291-327. Review.

PMID:
27671822
7.

Boswellic acids: biological actions and molecular targets.

Poeckel D, Werz O.

Curr Med Chem. 2006;13(28):3359-69. Review.

PMID:
17168710
8.

Pharmacological evidences for cytotoxic and antitumor properties of Boswellic acids from Boswellia serrata.

Khan MA, Ali R, Parveen R, Najmi AK, Ahmad S.

J Ethnopharmacol. 2016 Sep 15;191:315-323. doi: 10.1016/j.jep.2016.06.053. Epub 2016 Jun 21. Review.

PMID:
27346540
9.

Prospects of boswellic acids as potential pharmaceutics.

Du Z, Liu Z, Ning Z, Liu Y, Song Z, Wang C, Lu A.

Planta Med. 2015 Mar;81(4):259-71. doi: 10.1055/s-0034-1396313. Epub 2015 Feb 25. Review.

PMID:
25714728
10.

[Boswellic acids (the active agent in incense) for the treatment of chronic inflammatory diseases].

Ammon HP.

Med Monatsschr Pharm. 2003 Sep;26(9):309-15. Review. German. No abstract available.

PMID:
14526615
11.

Salai Guggal - Boswellia serrata: from a herbal medicine to a non-redox inhibitor of leukotriene biosynthesis.

Ammon HP.

Eur J Med Res. 1996 May 24;1(8):369-70. Review. No abstract available.

PMID:
9360935
12.

Frankincense ( rǔ xiāng; boswellia species): from the selection of traditional applications to the novel phytotherapy for the prevention and treatment of serious diseases.

Hamidpour R, Hamidpour S, Hamidpour M, Shahlari M.

J Tradit Complement Med. 2013 Oct;3(4):221-6. doi: 10.4103/2225-4110.119723. Review.

13.

Patented antiinflammatory plant drug development from traditional medicine.

Darshan S, Doreswamy R.

Phytother Res. 2004 May;18(5):343-57. Review.

PMID:
15173991
14.

Pentacyclic triterpenoic acids: new chemoprotective compounds. Minireview.

Ovesná Z, Vachálková A, Horváthová K, Tóthová D.

Neoplasma. 2004;51(5):327-33. Review.

PMID:
15640935
15.

Boswellia resin: from religious ceremonies to medical uses; a review of in-vitro, in-vivo and clinical trials.

Moussaieff A, Mechoulam R.

J Pharm Pharmacol. 2009 Oct;61(10):1281-93. doi: 10.1211/jpp/61.10.0003. Review.

PMID:
19814859
16.

Frankincense: systematic review.

Ernst E.

BMJ. 2008 Dec 17;337:a2813. doi: 10.1136/bmj.a2813. Review.

17.

Anti-inflammatory agents from plants: progress and potential.

Recio MC, Andujar I, Rios JL.

Curr Med Chem. 2012;19(14):2088-103. Review.

PMID:
22414101
18.

Inhibition of 5-lipoxygenase product synthesis by natural compounds of plant origin.

Werz O.

Planta Med. 2007 Oct;73(13):1331-57. Epub 2007 Oct 16. Review.

PMID:
17939102
19.

Omega-3 fatty acids in inflammation and autoimmune diseases.

Simopoulos AP.

J Am Coll Nutr. 2002 Dec;21(6):495-505. Review.

PMID:
12480795
20.

Bioactive constituents of myrrh and frankincense, two simultaneously prescribed gum resins in chinese traditional medicine.

Shen T, Lou HX.

Chem Biodivers. 2008 Apr;5(4):540-53. doi: 10.1002/cbdv.200890051. Review. No abstract available.

PMID:
18421746

Supplemental Content

Support Center